Related Experiment Video

Updated: Oct 9, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Serum urate and the risk of major coronary heart disease events

S G Wannamethee1, A G Shaper, P H Whincup

  • 1Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London, UK.

Heart (British Cardiac Society)
|August 1, 1997
PubMed

Insights

Serum urate is associated with coronary heart disease risk, particularly in men with prior myocardial infarction. However, it is not an independent risk factor, being linked to other metabolic factors.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Syndrome Research
  • Epidemiology

Background:

  • Elevated serum urate levels are common and associated with various health conditions.
  • Understanding the independent role of serum urate in cardiovascular disease (CVD) risk is crucial for clinical practice.

Purpose of the Study:

  • To investigate the relationship between serum urate and the risk of major coronary heart disease (CHD) events.
  • To determine if serum urate is an independent risk factor for CHD.

Main Methods:

  • Prospective study of 7688 men aged 40-59.
  • Follow-up for major fatal and non-fatal CHD events over an average of 16.8 years.
  • Statistical analysis adjusted for multiple cardiovascular risk factors.

Main Results:

  • Serum urate showed a positive association with CHD risk, influenced by factors like body mass index and blood pressure.
  • This association was attenuated by diastolic blood pressure and total cholesterol, with cholesterol being a critical factor.
  • A significant positive association was observed only in men with previous myocardial infarction.

Conclusions:

  • Serum urate is not an independent risk factor for CHD.
  • The association is dependent on pre-existing conditions like myocardial infarction and atherosclerosis.
  • Raised serum urate is part of a cluster of risk factors associated with insulin resistance syndrome.
Abstract

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.